Cannabis

GW Pharma's Justin Gover on marketing the first cannabis-based drug

GW Pharma's Justin Gover on marketing the first cannabis-based drug

By

11 questions for the GW CEO on the watershed moment.

FDA just approved the first prescription drug derived from marijuana: 4 outstanding questions

FDA just approved the first prescription drug derived from marijuana: 4 outstanding questions

By

The approval answers one question but raises others.

Marijuana: a green grey zone for patients, doctors, and pharma companies

Marijuana: a green grey zone for patients, doctors, and pharma companies

By

Legalization of the drug for medical use is already having an impact on prescription patterns. But for patients and doctors alike, there are a lot of unanswered questions.

Cannabis gets the iPhone treatment

Cannabis gets the iPhone treatment

By

Thanks to legalization, a new breed of startups are changing the nature of cannabis advertising.

Cannabis organization proposes national advertising regulations

Cannabis organization proposes national advertising regulations

By

The National Association of Cannabis Businesses has released the first national advertising rules for the cannabis industry.

NORML balances federal, local action after Cole memo reversal

NORML balances federal, local action after Cole memo reversal

By

Once Attorney General Jeff Sessions reversed the Cole memo, NORML began applying pressure both locally and nationally for changes in marijuana laws.

Five things for pharma marketers to know: Thursday, December 28, 2017

Five things for pharma marketers to know: Thursday, December 28, 2017

By

Study: male docs earn more than female peers; new Michigan law tackles opioid crisis; study: some docs billed Medicare for most expensive patient visit type

Cannabis nutrition company focuses on education

Cannabis nutrition company focuses on education

By

A particular focus is put on the emerging research about cannabis and its benefits for the human body.